Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3) : a double-blind, randomised, placebo-controlled, phase 3 trial

2021
journal article
article
111
dc.affiliationWydział Lekarski : Klinika Hematologiipl
dc.cm.date2022-04-08T06:12:13Z
dc.cm.id103923pl
dc.cm.idOmegaUJCM0083b6986a9a4534bd32e0d87f3718bbpl
dc.contributor.authorMatasar, Matthew J.pl
dc.contributor.authorCapra, Marcelopl
dc.contributor.authorÖzcan, Muhitpl
dc.contributor.authorLv, Fangfangpl
dc.contributor.authorLi, Weipl
dc.contributor.authorYanez, Eduardopl
dc.contributor.authorSapunarova, Katyapl
dc.contributor.authorLin, Tongyupl
dc.contributor.authorJin, Jiepl
dc.contributor.authorJurczak, Wojciech - 129923 pl
dc.contributor.authorHamed, Aryanpl
dc.contributor.authorWang, Ming-Chungpl
dc.contributor.authorBaker, Rosspl
dc.contributor.authorBondarenko, Igorpl
dc.contributor.authorZhang, Qingyuanpl
dc.contributor.authorFeng, Jifengpl
dc.contributor.authorGeissler, Klauspl
dc.contributor.authorLazaroiu, Mihaelapl
dc.contributor.authorSaydam, Guraypl
dc.contributor.authorSzomor, Árpádpl
dc.contributor.authorBouabdallah, Krimopl
dc.contributor.authorGaliulin, Rinatpl
dc.contributor.authorUchida, Toshikipl
dc.contributor.authorSoler, Lidia Mongaypl
dc.contributor.authorCao, Anjunpl
dc.contributor.authorHiemeyer, Florianpl
dc.contributor.authorMehra, Arunapl
dc.contributor.authorChilds, Barrett H.pl
dc.contributor.authorShi, Yuankaipl
dc.contributor.authorZinzani, Pier Luigipl
dc.date.accession2022-02-01pl
dc.date.accessioned2022-04-08T06:12:13Z
dc.date.available2022-04-08T06:12:13Z
dc.date.issued2021pl
dc.description.number5pl
dc.description.physical678-689pl
dc.description.volume22pl
dc.identifier.doi10.1016/S1470-2045(21)00145-5pl
dc.identifier.eissn1474-5488pl
dc.identifier.issn1470-2045pl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/289981
dc.languageengpl
dc.language.containerengpl
dc.rightsDodaję tylko opis bibliograficzny*
dc.rights.licenceBez licencji otwartego dostępu
dc.rights.uri*
dc.subtypeArticlepl
dc.titleCopanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3) : a double-blind, randomised, placebo-controlled, phase 3 trialpl
dc.title.journalThe Lancet Oncologypl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.affiliationpl
Wydział Lekarski : Klinika Hematologii
dc.cm.date
2022-04-08T06:12:13Z
dc.cm.idpl
103923
dc.cm.idOmegapl
UJCM0083b6986a9a4534bd32e0d87f3718bb
dc.contributor.authorpl
Matasar, Matthew J.
dc.contributor.authorpl
Capra, Marcelo
dc.contributor.authorpl
Özcan, Muhit
dc.contributor.authorpl
Lv, Fangfang
dc.contributor.authorpl
Li, Wei
dc.contributor.authorpl
Yanez, Eduardo
dc.contributor.authorpl
Sapunarova, Katya
dc.contributor.authorpl
Lin, Tongyu
dc.contributor.authorpl
Jin, Jie
dc.contributor.authorpl
Jurczak, Wojciech - 129923
dc.contributor.authorpl
Hamed, Aryan
dc.contributor.authorpl
Wang, Ming-Chung
dc.contributor.authorpl
Baker, Ross
dc.contributor.authorpl
Bondarenko, Igor
dc.contributor.authorpl
Zhang, Qingyuan
dc.contributor.authorpl
Feng, Jifeng
dc.contributor.authorpl
Geissler, Klaus
dc.contributor.authorpl
Lazaroiu, Mihaela
dc.contributor.authorpl
Saydam, Guray
dc.contributor.authorpl
Szomor, Árpád
dc.contributor.authorpl
Bouabdallah, Krimo
dc.contributor.authorpl
Galiulin, Rinat
dc.contributor.authorpl
Uchida, Toshiki
dc.contributor.authorpl
Soler, Lidia Mongay
dc.contributor.authorpl
Cao, Anjun
dc.contributor.authorpl
Hiemeyer, Florian
dc.contributor.authorpl
Mehra, Aruna
dc.contributor.authorpl
Childs, Barrett H.
dc.contributor.authorpl
Shi, Yuankai
dc.contributor.authorpl
Zinzani, Pier Luigi
dc.date.accessionpl
2022-02-01
dc.date.accessioned
2022-04-08T06:12:13Z
dc.date.available
2022-04-08T06:12:13Z
dc.date.issuedpl
2021
dc.description.numberpl
5
dc.description.physicalpl
678-689
dc.description.volumepl
22
dc.identifier.doipl
10.1016/S1470-2045(21)00145-5
dc.identifier.eissnpl
1474-5488
dc.identifier.issnpl
1470-2045
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/289981
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Dodaję tylko opis bibliograficzny
dc.rights.licence
Bez licencji otwartego dostępu
dc.rights.uri*
dc.subtypepl
Article
dc.titlepl
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3) : a double-blind, randomised, placebo-controlled, phase 3 trial
dc.title.journalpl
The Lancet Oncology
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
15
Views per month
Views per city
Ashburn
2
Bad Griesbach
2
Wroclaw
2
Dublin
1
Gorzów Wielkopolski
1
Krakow
1
Tokyo
1

No access

No Thumbnail Available